AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹1,159 Cr | ₹2,135 Cr | ₹619 Cr | ₹249 Cr | ₹168 Cr |
What is the latest Secured Loans ratio of AUROBINDO PHARMA ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹1,159 Cr |
| Mar2024 | ₹2,135 Cr |
| Mar2023 | ₹619 Cr |
| Mar2022 | ₹249 Cr |
| Mar2021 | ₹168 Cr |
How is Secured Loans of AUROBINDO PHARMA Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,159 Cr | -45.69 | |
| Mar2024 | ₹2,135 Cr | 244.92 | |
| Mar2023 | ₹619 Cr | 148.37 | |
| Mar2022 | ₹249 Cr | 47.91 | |
| Mar2021 | ₹168 Cr | - | |
Compare Secured Loans of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹89,584.0 Cr | -0.2% | 7.2% | 39.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.2% |
7.2% |
39.8% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses